GCM
Graham Capital Management Portfolio holdings
AUM
$3.28B
1-Year Return
7.17%
This Quarter Return
-1%
1 Year Return
+7.17%
3 Year Return
+21.95%
5 Year Return
+42.01%
10 Year Return
+61.8%
AUM
$2.9B
AUM Growth
-$616M
(-18%)
Cap. Flow
-$1.89B
Cap. Flow
% of AUM
-65.24%
Top 10 Holdings %
Top 10 Hldgs %
35.52%
Holding
1,434
New
418
Increased
270
Reduced
261
Closed
442
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
+$31.6M |
| 2 |
HES
Hess
HES
|
+$16.8M |
| 3 |
Coca-Cola
KO
|
+$16M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$13.9M |
| 5 |
Boston Scientific
BSX
|
+$13.8M |
Top Sells
| 1 |
Amazon
AMZN
|
+$27.6M |
| 2 |
Microsoft
MSFT
|
+$26.9M |
| 3 |
Dollar General
DG
|
+$22.7M |
| 4 |
Uber
UBER
|
+$21.3M |
| 5 |
NVIDIA
NVDA
|
+$19.1M |
Sector Composition
| 1 | Technology | 10.64% |
| 2 | Industrials | 7.41% |
| 3 | Financials | 6.89% |
| 4 | Consumer Discretionary | 5.06% |
| 5 | Healthcare | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Kennedy-Wilson Holdings
KW
$1.25B
| $331K | 0.01% |
34,027
-109,702
| -76% | -$1.07M |
|
652
EverQuote
EVER
$873M
| $330K | 0.01% |
+15,801
| New | +$330K |
|
653
Masco
MAS
$15.7B
| $328K | 0.01% |
4,915
-133,434
| -96% | -$8.9M |
|
654
Onto Innovation
ONTO
$5.34B
| $326K | 0.01% |
+1,486
| New | +$326K |
|
655
Kratos Defense & Security Solutions
KTOS
$11.6B
| $325K | 0.01% |
16,238
-31,952
| -66% | -$639K |
|
656
Castle Biosciences
CSTL
$674M
| $323K | 0.01% |
14,852
+2,662
| +22% | +$58K |
|
|
INVX
657
Innovex International, Inc.
INVX
$1.16B
| $323K | 0.01% |
17,377
+5,395
| +45% | +$100K |
|
|
OBE
658
Obsidian Energy
OBE
$409M
| $323K | 0.01% |
43,164
-187
| -0.4% | -$1.4K |
|
659
Lifestance Health
LFST
$2.02B
| $323K | 0.01% |
65,752
+48,423
| +279% | +$238K |
|
660
Bright Horizons
BFAM
$6.41B
| $322K | 0.01% |
+2,929
| New | +$322K |
|
661
Flex
FLEX
$21.9B
| $321K | 0.01% |
+10,900
| New | +$321K |
|
662
Eventbrite
EB
$263M
| $320K | 0.01% |
+66,055
| New | +$320K |
|
|
BPMC
663
DELISTED
Blueprint Medicines
BPMC
| $319K | 0.01% |
2,956
-30
| -1% | -$3.23K |
|
664
Harmony Biosciences
HRMY
$1.93B
| $317K | 0.01% |
10,523
-15,241
| -59% | -$460K |
|
665
Synaptics
SYNA
$2.74B
| $317K | 0.01% |
3,592
-6,811
| -65% | -$601K |
|
666
LGI Homes
LGIH
$1.45B
| $316K | 0.01% |
3,535
-1,248
| -26% | -$112K |
|
667
Klaviyo
KVYO
$9.46B
| $315K | 0.01% |
+12,675
| New | +$315K |
|
668
Ardelyx
ARDX
$1.6B
| $315K | 0.01% |
42,531
+22,647
| +114% | +$168K |
|
669
BlackLine
BL
$3.39B
| $315K | 0.01% |
+6,495
| New | +$315K |
|
|
ITCI
670
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $312K | 0.01% |
4,553
-12,554
| -73% | -$860K |
|
671
Grindr
GRND
$3.01B
| $312K | 0.01% |
25,453
+12,472
| +96% | +$153K |
|
672
Insperity
NSP
$1.99B
| $310K | 0.01% |
+3,404
| New | +$310K |
|
673
Oil States International
OIS
$348M
| $310K | 0.01% |
69,819
+41,611
| +148% | +$185K |
|
674
4D Molecular Therapeutics
FDMT
$324M
| $307K | 0.01% |
+14,649
| New | +$307K |
|
|
BRKL
675
DELISTED
Brookline Bancorp
BRKL
| $307K | 0.01% |
+36,816
| New | +$307K |
|